TriSalus Life Sciences (TLSIW) Competitors $1.51 +0.13 (+9.42%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestTrends TLSIW vs. AIMDW, BBLGW, DHAIW, COCHW, HSCSW, IINNW, NXLIW, PAVMZ, PETVW, and QSIAWShould you be buying TriSalus Life Sciences stock or one of its competitors? The main competitors of TriSalus Life Sciences include Ainos (AIMDW), Bone Biologics (BBLGW), DIH Holding US (DHAIW), Envoy Medical (COCHW), Heart Test Laboratories (HSCSW), Inspira Technologies Oxy B.H.N. (IINNW), Nexalin Technology (NXLIW), PAVmed (PAVMZ), PetVivo (PETVW), and Quantum-Si (QSIAW). These companies are all part of the "medical devices" industry. TriSalus Life Sciences vs. Ainos Bone Biologics DIH Holding US Envoy Medical Heart Test Laboratories Inspira Technologies Oxy B.H.N. Nexalin Technology PAVmed PetVivo Quantum-Si TriSalus Life Sciences (NASDAQ:TLSIW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, community ranking, valuation, profitability, risk, dividends, earnings and analyst recommendations. Do analysts prefer TLSIW or AIMDW? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TriSalus Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AAinos 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the media refer more to TLSIW or AIMDW? In the previous week, TriSalus Life Sciences had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for TriSalus Life Sciences and 0 mentions for Ainos. TriSalus Life Sciences' average media sentiment score of 0.59 beat Ainos' score of 0.21 indicating that TriSalus Life Sciences is being referred to more favorably in the media. Company Overall Sentiment TriSalus Life Sciences Positive Ainos Neutral Is TLSIW or AIMDW more profitable? Company Net Margins Return on Equity Return on Assets TriSalus Life SciencesN/A N/A N/A Ainos N/A N/A N/A Does the MarketBeat Community prefer TLSIW or AIMDW? TriSalus Life Sciences and Ainos both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformTriSalus Life SciencesN/AN/AAinosN/AN/A Which has stronger valuation and earnings, TLSIW or AIMDW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTriSalus Life Sciences$24.74MN/AN/AN/AN/AAinos$65.12KN/AN/AN/AN/A SummaryTriSalus Life Sciences beats Ainos on 3 of the 3 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get TriSalus Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSIW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLSIW vs. The Competition Export to ExcelMetricTriSalus Life SciencesMedical Devices IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.79B$5.02B$8.43BDividend YieldN/A2.48%7.52%4.16%P/E RatioN/A195.02128.7716.66Price / SalesN/A191.811,724.9679.31Price / CashN/A15.5136.9133.53Price / BookN/A3.344.605.19Net IncomeN/A$66.48M$114.09M$223.67M7 Day Performance25.83%-1.02%110.41%2.70%1 Month Performance45.19%-2.24%124.29%8.76%1 Year Performance556.52%38.23%154.67%28.76% TriSalus Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLSIWTriSalus Life SciencesN/A$1.51+9.4%N/A+500.0%$0.00$24.74M0.00107AIMDWAinosN/A$0.03-47.5%N/AN/A$0.00$65,122.000.0040Positive NewsBBLGWBone BiologicsN/A$32.24+7.5%N/A+1,352.3%$0.00N/A0.002Gap UpDHAIWDIH Holding USN/A$0.04+10.0%N/AN/A$0.00$64.47M0.00N/AGap UpCOCHWEnvoy MedicalN/A$0.10+87.5%N/A+505.6%$0.00$302,000.000.0034Gap UpHSCSWHeart Test LaboratoriesN/A$0.03-21.8%N/AN/A$0.00$18,600.000.0010News CoveragePositive NewsIINNWInspira Technologies Oxy B.H.N.N/A$0.38-7.3%N/A+192.9%$0.00N/A0.0020Gap DownNXLIWNexalin TechnologyN/A$0.22-38.9%N/A+2,193.0%$0.00$150,159.000.006Gap DownPAVMZPAVmedN/A$0.02-62.0%N/AN/A$0.00$3.83M0.0090Gap DownPETVWPetVivoN/A$0.03-6.9%N/AN/A$0.00$1.05M0.0025Gap UpQSIAWQuantum-SiN/A$0.07+6.0%N/A-67.4%$0.00$1.70M0.00159Gap Down Related Companies and Tools Related Companies AIMDW Alternatives BBLGW Alternatives DHAIW Alternatives COCHW Alternatives HSCSW Alternatives IINNW Alternatives NXLIW Alternatives PAVMZ Alternatives PETVW Alternatives QSIAW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TLSIW) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
